Search

  3. ProQR to Host R&D Day in New York on January 29

    Press release

    LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & Development Day for investors on Tuesday, January 29 at 8:00 am ET at the Lotte New York Palace Hotel in New York, NY.

  6. ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer

    Press release

    … ProQR Appoints David M. Rodman, MD as Chief Development … the Netherlands, March 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that it … of RNA approaches to treating disease.” said Noreen R. Henig, MD, Chief Medical Officer. “There are very few …

  8. ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board

    Press release

    LEIDEN, the Netherlands, May 23, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced the appointment of Dr.

  10. ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July

    Press release

    … ProQR Announces Presentations on Programs in Ophthalmology at … LEIDEN, the Netherlands, July 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … II       Presentation at OIS Retina Daniel de Boer, CEO of ProQR, will give a presentation highlighting the company’s …